The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; MSD Oncology
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; MSD/AstraZeneca
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - MSD/AstraZeneca
A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.
 
Fernanda Bronzon Damian
No Relationships to Disclose
 
Andreia Cristina De Melo
Honoraria - AstraZeneca; BMS; GlaxoSmithKline; MSD Oncology; Novartis; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Novartis
Research Funding - AstraZeneca (Inst); BMS Brazil (Inst); Clovis Oncology (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Graziela Zibetti Dal Molin
No Relationships to Disclose
 
Angelica Nogueira Rodrigues
Leadership - Eva; Latin American Cooperative Oncology Group (LACOG); SBOC
Stock and Other Ownership Interests - Dom Oncologia
Honoraria - AstraZeneca; Daiichi Sankyo Pharmaceutical; EISAI; GlaxoSmithKline; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Aknar Freire de Carvalho Calabrich
Employment - Clínica AMO
Stock and Other Ownership Interests - Clínica AMO
Honoraria - AstraZeneca; BMS Brazil; GlaxoSmithKline; Janssen Oncology; MSD Oncology; Roche; Sanofi/Aventis; Takeda
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; MSD Oncology; Pfizer
Speakers' Bureau - AstraZeneca; BMS Brazil; GlaxoSmithKline; Janssen Oncology; MSD Oncology; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Janssen Oncology
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; MSD Oncology
 
Gustavo Werutsky
Honoraria - AstraZeneca/MedImmune; Libbs; Merck; Pfizer
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb Brazil (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis; Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech
 
Elias Abdo Filho
No Relationships to Disclose
 
Taiane Francieli Rebelatto
No Relationships to Disclose
 
Rafaela Gomes de Jesus
No Relationships to Disclose
 
Mirela Foresti Jimenez
No Relationships to Disclose